Quoted from http://www.reuters.com/article/governmentFilingsNews/idUSBNG7944120091026
Matrixx says FDA unwilling to change stance on Zicam
Oct 26 (Reuters) - Matrixx Initiatives Inc said the U.S. health regulator has indicated that it is unwilling to reverse its position regarding the warning letter issued on company's nasal versions of Zicam cold remedy.
In June, the company voluntarily withdrew two of its existing Zicam products after the U.S. Food and Drug Administration issued a warning letter that the products could cause a loss of smell. [ID:nN24151638]